- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Biostem Technologies Inc (BSEM)
Biostem Technologies Inc stock price live, this page displays OTC BSEM stock exchange data. View the BSEM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Biostem Technologies Inc real time stock price chart below.
What Is the Biostem Technologies Inc Stock Price Today?
The Biostem Technologies Inc stock price today is 4.3200.
What Is the Stock Symbol for Biostem Technologies Inc?
The stock symbol for Biostem Technologies Inc is "BSEM."
What Stock Exchange Does Biostem Technologies Inc Trade On?
Biostem Technologies Inc is listed and trades on the OTC Markets stock exchange.
Is Biostem Technologies Inc a Good Stock to Buy?
Determining whether Biostem Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BSEM quote. (ISIN: US0906842002)
What Is the Biostem Technologies Inc Stock Price Today?
The Biostem Technologies Inc stock price today is 4.3200.
What Is the Stock Symbol for Biostem Technologies Inc?
The stock symbol for Biostem Technologies Inc is "BSEM."
What Stock Exchange Does Biostem Technologies Inc Trade On?
Biostem Technologies Inc is listed and trades on the OTC Markets stock exchange.
Is Biostem Technologies Inc a Good Stock to Buy?
Determining whether Biostem Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BSEM quote. (ISIN: US0906842002)
4.3200
-0.7138(-14.18%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.0000
4.5300
52 wk Range
3.0932
14.5200
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.00004.5300
52 wk Range
3.093214.5200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BSEM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
7.0000
Upside
+62.04%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Biostem Tech receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Biostem Tech receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.0000
(+62.04% Upside)
Biostem Technologies Inc Earnings Call Summary for Q1/2026
- BioStem Technologies Q1 2026 revenue of $6.1M missed forecast of $64.2M; EPS of -$0.52 vs. expected $0.04, stock fell 0.81% to $5.075.
- Gross margin plunged to 61% from 97% in Q4 2025; operating expenses cut 27% to $12.6M through elimination of bad debt expenses.
- Cash position declined $15.8M due to acquisition costs; recent acquisition contributed only 70 days to quarterly results.
- Management targeting hospital market expansion and sales force integration to drive growth in second half of 2026 despite integration challenges.
- CEO Matuszewski cited expanded product portfolio as growth driver; CFO Poe emphasized cost optimization efforts to improve path to profitability.
Last Updated: 2026-05-14, 05:40 p/m
Read Full TranscriptEarnings
Latest Release
May 14, 2026
EPS / Forecast
-0.52 / 0.04
Revenue / Forecast
6.14M / 64.2M
Compare BSEM to Peers and Sector
Metrics to compare | BSEM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBSEMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −10.7x | 17.4x | −0.5x | |
PEG Ratio | 0.08 | 0.19 | 0.00 | |
Price/Book | 1.8x | 3.6x | 2.6x | |
Price / LTM Sales | 1.5x | 1.5x | 3.2x | |
Upside (Analyst Target) | - | 212.5% | 52.3% | |
Fair Value Upside | Unlock | 24.9% | 8.8% | Unlock |
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Caribbean International Holdings Inc. and changed its name to BioStem Technologies, Inc. in August 2014. BioStem Technologies, Inc. was incorporated in 2006 and is based in Fort Lauderdale, Florida.
People Also Watch
FAQ
What Is the Biostem Tech (BSEM) Stock Price Today?
The Biostem Tech stock price today is 4.3200 USD.
What Stock Exchange Does Biostem Tech Trade On?
Biostem Tech is listed and trades on the OTC Markets.
What Is the Stock Symbol for Biostem Tech?
The stock symbol for Biostem Tech is "BSEM."
What Is the Biostem Tech Market Cap?
As of today, Biostem Tech market cap is 73.2600M USD.
What Is Biostem Tech's Earnings Per Share (TTM)?
The Biostem Tech EPS (TTM) is -0.3930.
When Is the Next Biostem Tech Earnings Date?
Biostem Tech will release its next earnings report on Aug 25, 2026.
From a Technical Analysis Perspective, Is BSEM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Biostem Tech Stock Split?
Biostem Tech has split 5 times.
How Many Employees Does Biostem Tech Have?
Biostem Tech has 33 employees.
What is the current trading status of Biostem Tech (BSEM)?
As of May 16, 2026, Biostem Tech (BSEM) is trading at a price of 4.3200 USD, with a previous close of 5.0338 USD. The stock has fluctuated within a day range of 4.0000 USD to 4.5300 USD, while its 52-week range spans from 3.0932 USD to 14.5200 USD.
What Is Biostem Tech (BSEM) Price Target According to Analysts?
The average 12-month price target for Biostem Tech is 7.0000 USD, with a high estimate of 7 USD and a low estimate of 7 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +62.04% Upside potential.
What Is the BSEM After Hours Price?
BSEM's last after hours stock price is 5.1500 USD, the stock has decreased by 0.0180, or 0.3500%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.